4th Quarter - Amendment

BUCHANAN INGERSOLL & ROONEY PC for AIM IMMUNOTECH INC.

Firm
Client
Income
$40,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 10, 2022 $40,000 Replaced
4th Quarter - Amendment (this page) Jan 10, 2022 $40,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. FY 2022 Appropriations for Defense Department, and National Institutes of Health (NIH)

LobbyistCovered position, as disclosed
KYLE A DARBY New —
EDWARD HILD Chief of Staff, Sen. Lisa Murkowski; Deputy Chief of Staff, Sen. Pete Domenici
MICHAEL P STRAZZELLA —
JAMES C WILTRAUT —

Contacted: Defense, Dept of (DOD); SENATE; Navy, Dept of; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA)

Pharmacy PHA

Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. FY 2022 Appropriations for Defense Department, and National Institutes of Health (NIH)

LobbyistCovered position, as disclosed
KYLE A DARBY New —
EDWARD HILD Chief of Staff, Sen. Lisa Murkowski; Deputy Chief of Staff, Sen. Pete Domenici
MICHAEL P STRAZZELLA —
JAMES C WILTRAUT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Defense, Dept of (DOD); Navy, Dept of; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.